Bluejay Diagnostics, Inc.
BJDX
$1.47
$0.021.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.95% | -30.20% | 3.37% | 40.13% | -6.31% |
| Total Depreciation and Amortization | -26.01% | 38.40% | -30.04% | -0.19% | -1.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -184.62% | 100.26% | -360.60% | -38.81% | 2,535.29% |
| Change in Net Operating Assets | -121.50% | 301.80% | 122.43% | -459.68% | 612.47% |
| Cash from Operations | -73.36% | 31.85% | 9.98% | -0.86% | 16.74% |
| Capital Expenditure | -- | -- | -450.00% | 99.93% | -662.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -450.00% | 99.93% | -662.71% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 0.00% | -100.35% | 177.07% | 79.95% | -205,844.44% |
| Issuance of Common Stock | -- | -- | -100.00% | -99.99% | 144.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -59.41% |
| Cash from Financing | 338,200.00% | -100.35% | 177.09% | -104.89% | 171.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.91% | 18.43% | 36.87% | -142.66% | 1,092.22% |